| An mRNA vaccine against SARS-CoV-2—preliminary report LA Jackson, EJ Anderson, NG Rouphael, PC Roberts, M Makhene, ... New England journal of medicine 383 (20), 1920-1931, 2020 | 3716 | 2020 |
| Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 States, March 1–30, 2020 S Garg MMWR. Morbidity and mortality weekly report 69, 2020 | 3143 | 2020 |
| Community-acquired pneumonia requiring hospitalization among US adults S Jain, WH Self, RG Wunderink, S Fakhran, R Balk, AM Bramley, C Reed, ... New England Journal of Medicine 373 (5), 415-427, 2015 | 2623 | 2015 |
| Community-acquired pneumonia requiring hospitalization among US children S Jain, DJ Williams, SR Arnold, K Ampofo, AM Bramley, C Reed, ... New England Journal of Medicine 372 (9), 835-845, 2015 | 1946 | 2015 |
| Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults EJ Anderson, NG Rouphael, AT Widge, LA Jackson, PC Roberts, ... New England Journal of Medicine 383 (25), 2427-2438, 2020 | 1726 | 2020 |
| Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans PS Arunachalam, F Wimmers, CKP Mok, RAPM Perera, M Scott, T Hagan, ... Science 369 (6508), 1210-1220, 2020 | 1163 | 2020 |
| Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 1098 | 2022 |
| Durability of responses after SARS-CoV-2 mRNA-1273 vaccination AT Widge, NG Rouphael, LA Jackson, EJ Anderson, PC Roberts, ... New England Journal of Medicine 384 (1), 80-82, 2021 | 845 | 2021 |
| Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US coronavirus disease 2019 (COVID-19)-associated … L Kim, S Garg, A O’Halloran, M Whitaker, H Pham, EJ Anderson, ... Clinical infectious diseases 72 (9), e206-e214, 2021 | 722 | 2021 |
| Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19 N Doria-Rose, MS Suthar, M Makowski, S O’Connell, AB McDermott, ... New England Journal of Medicine 384 (23), 2259-2261, 2021 | 720 | 2021 |
| Hospitalization rates and characteristics of children aged 18 years hospitalized with laboratory-confirmed COVID-19—COVID-NET, 14 states, March 1–July 25, 2020 L Kim MMWR. Morbidity and mortality weekly report 69, 2020 | 682 | 2020 |
| Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase HM El Sahly, LR Baden, B Essink, S Doblecki-Lewis, JM Martin, ... New England Journal of Medicine 385 (19), 1774-1785, 2021 | 605 | 2021 |
| Rapid generation of neutralizing antibody responses in COVID-19 patients MS Suthar, MG Zimmerman, RC Kauffman, G Mantus, SL Linderman, ... Cell Reports Medicine 1 (3), 2020 | 589 | 2020 |
| Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants A Pegu, SE O’Connell, SD Schmidt, S O’Dell, CA Talana, L Lai, J Albert, ... Science 373 (6561), 1372-1377, 2021 | 583 | 2021 |
| Rotavirus infection in adults EJ Anderson, SG Weber The Lancet infectious diseases 4 (2), 91-99, 2004 | 520 | 2004 |
| Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19—COVID-NET, 13 States, March 1–August 22, 2020 MJ Delahoy MMWR. Morbidity and mortality weekly report 69, 2020 | 472 | 2020 |
| Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells KW Cohen, SL Linderman, Z Moodie, J Czartoski, L Lai, G Mantus, ... Cell Reports Medicine 2 (7), 2021 | 462 | 2021 |
| Hospitalizations associated with COVID-19 among children and adolescents—COVID-NET, 14 states, March 1, 2020–August 14, 2021 MJ Delahoy MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 328 | 2021 |
| Effects of influenza vaccination in the United States during the 2017–2018 influenza season MA Rolfes, B Flannery, JR Chung, A O’Halloran, S Garg, EA Belongia, ... Clinical Infectious Diseases 69 (11), 1845-1853, 2019 | 323 | 2019 |
| Risk factors for severe COVID-19 in children RC Woodruff, AP Campbell, CA Taylor, SJ Chai, B Kawasaki, J Meek, ... Pediatrics 149 (1), e2021053418, 2022 | 305 | 2022 |
